Transaction DateRecipientSharesTypePriceValue
4th January 2021Eric Forman2,364Bona fide gift$0.00
30th December 2020Eric Forman2,900Bona fide gift$0.00
14th December 2020Robert Greenberg883Bona fide gift$0.00
3rd December 2020Robert Greenberg250,000Conversion of derivative$0.00
3rd December 2020Robert Greenberg250,000Open or private sale$34.05$8,511,550.00
30th November 2020Stephen J. Forman21,053Open or private purchase$4.75$100,001.75
30th November 2020Philip F Palmedo21,053Open or private purchase$4.75$100,001.75
30th November 2020Robert Greenberg52,632Open or private purchase$4.75$250,002.00
11th September 2020Robert Greenberg150,000Sale back to the issuer$0.00
11th September 2020Robert Greenberg150,000Sale back to the issuer$0.00
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.



Ticker: LIXT.OB
Sector: Unknown
Industry: Unknown
SEC Central Index Key (CIK): 1335105
Employees:
Exchange: None
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals